SCHEMBL3807805

SCHEMBL3807805

COc1ccccc1P(=O)(CCP(=O)(c1ccccc1)c1ccccc1OC)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.73
▸ MEN1 O00255 3/20 0.73
▸ L3MBTL1 Q9Y468 2/20 0.60
▸ HTT P42858 2/20 0.60
▸ ALDH1A1 P00352 4/20 0.47
▸ POLB P06746 1/20 0.46
▸ MAPT P10636 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ ALPG P10696 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ NPY1R P25929 1/20 0.46
▸ NPY2R P49146 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ HIF1A Q16665 1/20 0.44
▸ LMNA P02545 2/20 0.44
▸ RECQL P46063 1/20 0.44
▸ NPC1 O15118 1/20 0.42
▸ CTSD P07339 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29396406 1.00 KMT2A (0.73) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL28685764 1.00 KMT2A (0.73) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL24308948 0.89 KMT2A (0.79) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL23658897 0.89 KMT2A (0.64) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL23658968 0.89 KMT2A (0.64) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL15715540 0.86 KMT2A (0.69) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL3787871 0.82 KMT2A (0.52) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL31326108 0.82 MEN1 (0.56) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL6828371 0.80 KMT2A (0.61) KMT2AMEN1L3MBTL1HTTALDH1A1
SCHEMBL23658965 0.79 KMT2A (0.60) KMT2AMEN1L3MBTL1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114133412-B Preparation method of chiral 1, 2-bis [ (2-methoxyphenyl) phenylphosphinyl ] ethane 河南工程学院 2023-11-07 — — CN claimed
US-8471067-B2 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile UNIVERSITY COLLEGE DUBLIN (IE) 2013-06-25 — — US claimed
WO-2010004278-A1 METHOD FOR INCREASING THE ENANTIOMERIC EXCESS OF CHIRAL PHOSPHINE OXIDES, SULPHIDES, IMIDES AND BORANES CELTIC CATALYSTS LIMITED (IE) 2010-01-14 — — WO claimed
US-20080255391-A1 Chiral Phosphorus Compounds UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND (IE) 2008-10-16 — — US claimed
JP-2008501010-A — — 2008-01-17 — — JP claimed
EP-1751170-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2007-02-14 — — EP claimed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 — — WO claimed
US-4008281-A BIS-PHOSPHINE MONSANTO COMPANY (US) 1977-02-15 — — US claimed
CN-117843679-A Fluorine-containing biphosphine compound and preparation method thereof 四川轻化工大学 2024-04-09 — — CN disclosed
CN-117447464-A Method for producing optically active compound 首日生物制药公司 2024-01-26 — — CN disclosed
CN-114133412-B Preparation method of chiral 1, 2-bis [ (2-methoxyphenyl) phenylphosphinyl ] ethane 河南工程学院 2023-11-07 — — CN disclosed
CN-114133412-B Preparation method of chiral 1, 2-bis [ (2-methoxyphenyl) phenylphosphinyl ] ethane 河南工程学院 2023-11-07 — — CN disclosed
CN-114133412-B Preparation method of chiral 1, 2-bis [ (2-methoxyphenyl) phenylphosphinyl ] ethane 河南工程学院 2023-11-07 — — CN disclosed
CN-111032047-B Method for producing optically active compound 多特疗法-1公司 2023-10-27 — — CN disclosed
WO-2005118603-A1 CHIRAL PHOSPHORUS COMPOUNDS UNIVERSITY COLLEGE DUBLIN (IE) 2005-12-15 — — WO disclosed
US-4939288-A Catalytic hydrogenation MONSANTO COMPANY (US) 1990-07-03 — — US disclosed
EP-0229944-A2 Novel tetrahydroisoquinoline derivatives SYNTEX (U.S.A.) INC. (US) 1987-07-29 — — EP disclosed
US-4220590-A OPTICALLY ACTIVE BIS PHOSPHINE COMPOUNDS MONSANTO COMPANY (US) 1980-09-02 — — US disclosed
US-4142992-A ASYMMETRIC CATALYSIS MONSANTO COMPANY (US) 1979-03-06 — — US disclosed
US-4008281-A BIS-PHOSPHINE MONSANTO COMPANY (US) 1977-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255391-A1 Chiral Phosphorus Compounds PHOSPHO1, PNKP, PTMS KMT2A 3836/4885MEN1 3668/4885L3MBTL1 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback